RECEPTOPHARM, INC.
Receptopharm is a bio-pharmaceutical company developing proprietary therapeutic proteins for the treatment of several chronic, life-threatening viral, auto-immune and neuro-degenerative disorders, specifically including Rabies, HIV, and Myasthenia gravis (MG).
RECEPTOPHARM, INC.
Industry:
Biotechnology Health Care
Founded:
2001-01-01
Address:
Plantation, Florida, United States
Country:
United States
Status:
Active
Contact:
(954)356-1460
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
More informations about "ReceptoPharm, Inc."
ReceptoPharm, Inc. - Crunchbase Company Profile & Funding
Receptopharm is a bio-pharmaceutical company developing proprietary therapeutic proteins for the treatment of several chronic, life-threatening viral, auto-immune and neuro-degenerative …See details»
ReceptoPharm Company Profile 2024: Valuation, Investors
Operator of a biopharmaceutical company developing proprietary therapeutic proteins for the treatment of viral and neurological diseases.See details»
Receptopharm Inc - Company Profile and News - Bloomberg …
Receptopharm, Inc. is a bio-pharmaceutical company developing proprietary therapeutic proteins for the treatment of several chronic, life-threatening viral, auto-immune and neuro-degenerative...See details»
ReceptoPharm Company Profile - Office Locations, Competitors
ReceptoPharm is a biopharmaceutical drug discovery company. Its primary focus is on the treatment of viral and neurological diseases. The emphasis of ReceptoPharm's approach to …See details»
ReceptoPharm, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ReceptoPharm, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 3 literature, Disease Domain:Nervous System Diseases, Hemic and Lymphatic …See details»
ReceptoPharm, Inc. acquired by Nutra Pharma - Crunchbase
Dec 15, 2003 · ReceptoPharm, Inc. ReceptoPharm, Inc is a bio-pharmaceutical company developing proprietary therapeutic proteins for the treatment of several chronic.See details»
ReceptoPharm, Inc. - Crunchbase
ReceptoPharm, Inc is a bio-pharmaceutical company developing proprietary therapeutic proteins for the treatment of several chronic.See details»
ReceptoPharm, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ReceptoPharm, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 1 literature, Disease Domain:Nervous System Diseases, Immune System Diseases, …See details»
Nutra Pharma Corp. Subsidiary, Receptopharm, Inc., Receives
May 19, 2008 · BOCA RATON, Fla.-- (BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has …See details»
Nutra Pharma Acquires Remaining Interest in Biopharmaceutical …
Apr 14, 2008 · ReceptoPharm is currently studying RPI-MN as a treatment for HIV and RPI-78M as a treatment for Multiple Sclerosis (MS) and Adrenomyeloneuropathy (AMN). In December, …See details»
Articles about Receptopharm, Inc. - BioSpace
Apr 11, 2007 · 14 articles about Receptopharm, Inc. Nutra Pharma Corp. Subsidiary, Receptopharm, Inc. Introduces Cost Effective Contract Research Services for Early Stage Life …See details»
Nutra Pharma Corp. Announces Receptopharm, Inc.'s Joint
Mar 7, 2007 · BOCA RATON, Fla.-- (BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has today …See details»
Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application …
Feb 9, 2009 · BOCA RATON, Fla.-- (BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV …See details»
ReceptoPharm, Inc. - Updates, News, Events, Signals & Triggers
ReceptoPharm, Inc is a bio-pharmaceutical company developing proprietary therapeutic proteins for the treatment of several chronic.See details»
Recombinant erythropoietin biosimilar(ReceptoPharm, Inc.)
Now, its global highest R&D status is Approved, Mechanism: EPO receptor agonists (Erythropoietin receptor agonists), Therapeutic Areas: Hemic and Lymphatic Diseases, Active …See details»
Cobra toxin(ReceptoPharm, Inc.) - Drug Targets, Indications
Cobra toxin(ReceptoPharm, Inc.): a Muscle-type nAChRs antagonists Drug, Initially developed by ReceptoPharm, Inc., Now, its global highest R&D status is Approved, Mechanism: Muscle …See details»
Hanoi - KPMG Vietnam
For more detail about the structure of the KPMG global organization please visit https://kpmg.com/governance.See details»
Tòa nhà Keangnam Hanoi Landmark Tower. Văn phòng Hạng A
♦ Là tòa tháp cao thứ 2 tại Hà Nội, được xem là "biểu tượng" cho sự phát triển kinh tế của Việt Nam và hình ảnh đại diện của khu vực phía tây Hà Nội nói riêng, thủ đô Hà Nội nói chung. ♦ …See details»
Tòa nhà HH4 Tower (Tòa nhà Sông Đà), Mỹ Đình, Q. Nam Từ Liêm
HH4 Sông Đà Mỹ Đình là tòa nhà văn phòng cho thuê, kết hợp khối dịch vụ nằm trong khu đô thị mới Mỹ Đình - Mễ Trì, được đầu tư bởi Tập đoàn Sông Đà. Đây cũng là trụ sở làm việc chính …See details»
Russian Hackers Breached a DC-Area Organization Through a
22 hours ago · The attackers then found a laptop at the second organization that had both ethernet and Wi-Fi connections and used that device’s Wi-Fi adapter and the compromised Wi …See details»